+104.0%
EMR vs USFR
+14.3%
+89.6%
-29.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | USFR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.2% | 0.0% | -1.2% | -0.9% |
| 7D | +0.7% | +0.1% | +0.6% | +1.1% |
| 30D | +3.5% | +0.4% | +3.1% | +5.7% |
| 3M | +5.9% | +1.1% | +4.9% | +12.1% |
| 6M | +19.4% | +2.1% | +17.4% | +32.7% |
| YTD | +27.7% | +3.4% | +24.2% | +47.4% |
| 1Y | +30.9% | +4.1% | +26.8% | +52.9% |
| All | +104.0% | +14.3% | +89.6% | +222.4% |
Cumulative growth
Daily Returns
Daily percentage return beside USFR.
Daily Out/Under-Performance
Portfolio return minus USFR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × USFR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded USFR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling